Zoetis ( (ZTS) ) has released its Q4 earnings. Here is a breakdown of the information Zoetis presented to its investors.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Zoetis, a leading animal health company, specializes in the development and marketing of veterinary vaccines and medicines worldwide, catering to the needs of veterinarians, livestock producers, and pet owners with a diverse portfolio of products.
Zoetis reported strong financial performance for the fourth quarter and full year 2024, with revenue reaching $2.3 billion in Q4, marking a 5% increase from the previous year. The company’s net income for the quarter was $581 million, reflecting an 11% growth, while adjusted net income stood at $632 million, up by 11% as well. For the full year, Zoetis achieved a revenue of $9.3 billion, an 8% increase year-over-year, with net income rising to $2.5 billion.
The financial highlights of Zoetis include an operational revenue growth of 6% in Q4 2024, and an impressive 11% for the full year, excluding foreign exchange impacts. Notably, the divestiture of certain product lines resulted in a 9% organic operational growth in Q4. In the U.S. market, companion animal products, led by popular brands like Simparica Trio and Librela, saw a 7% increase in sales, while the international segment experienced a 10% operational revenue growth, driven by strong demand for dermatology and parasiticide products.
Looking forward, Zoetis provided guidance for 2025, projecting revenue between $9.225 and $9.375 billion, with anticipated organic operational growth of 6% to 8%. The company remains optimistic about sustaining its growth trajectory, supported by its innovative product pipeline and robust market demand, as articulated by CEO Kristin Peck.
Overall, Zoetis continues to demonstrate resilience and adaptability in the dynamic animal health sector, positioning itself for sustained growth through strategic investments and market expansion initiatives.
